Imetelstat Combination Therapy
A Phase 1 Study of GRN163L (Imetelstat) in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia That is in Second or Greater Relapse or That is Refractory to Relapse Therapy; Myelodysplastic Syndrome or Juvenile Myelomonocytic Leukemia in First or Greater Relapse or is Refractory to Relapse Therapy
Near Add Your Location
Sorting 15 by
St. Jude Children's Research Center
Memphis, TN
- Accepting patients
- Accepting patients
Children's Hospital of Philadelphia
Philadelphia, PA
- Accepting patients
UPMC Children's Hospital of Pittsburgh
Pittsburgh, PA
- Accepting patients
Children's of Alabama
Birmingham, AL
- Accepting patients
Children's Hospital Orange County
Orange, CA
- Accepting patients
Center of Excellence
University of Minnesota - Masonic Cancer Center
Minneapolis, MN
- Accepting patients
- Accepting patients
UCSF Helen Diller Comprehensive Cancer Center
University of California San Francisco
San Francisco, CA
- Accepting patients
The Children's Hospital of Colorado
Aurora, CO
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.